Guardant Health, Inc. (GH) Institutional Ownership & Insider Trading

594 institutions reported holding Guardant Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 145 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GHGuardant Health, Inc.Follow GH — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 22.7B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

594 institutions held 99.8% of the shares. Across filers that reported both quarters, shares held changed -2.6%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	594	134	-2.6%	190	133	161	31
Mar 26	479	135	+4.4%	172	54	152	64
Dec 25	487	133	+7.2%	145	105	142	25
Sep 25	382	123	-0.7%	118	57	120	31
Jun 25	358	124	+3.5%	117	61	109	35
Mar 25	334	118	+0.1%	83	75	102	40
Dec 24	294	119	-4.4%	90	48	79	22
Sep 24	262	123	+7.3%	83	34	67	52

Guardant Health, Inc. — questions

Who owns Guardant Health, Inc. stock?: 594 institutions reported Guardant Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (5.7%), PRICE T ROWE ASSOCIATES INC /MD/ (4.8%), VANGUARD CAPITAL MANAGEMENT LLC (4.3%).
Are Guardant Health, Inc. insiders buying or selling?: 145 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Guardant Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.